AMGN Cash-Secured Put Strategy

AMGN (Amgen Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NASDAQ.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels.

AMGN (Amgen Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $181.58B, a trailing P/E of 23.29, a beta of 0.44 versus the broader market, a 52-week range of 264.15-391.29, average daily share volume of 2.6M, a public-listing history dating back to 1983, approximately 28K full-time employees. These structural characteristics shape how AMGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.44 indicates AMGN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. AMGN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a cash-secured put on AMGN?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current AMGN snapshot

As of May 15, 2026, spot at $327.19, ATM IV 23.85%, IV rank 22.47%, expected move 6.84%. The cash-secured put on AMGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this cash-secured put structure on AMGN specifically: AMGN IV at 23.85% is on the cheap side of its 1-year range, which means a premium-selling AMGN cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 6.84% (roughly $22.37 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMGN should anchor to the underlying notional of $327.19 per share and to the trader's directional view on AMGN stock.

AMGN cash-secured put setup

The AMGN cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMGN near $327.19, the first option leg uses a $310.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMGN chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMGN shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$310.00$2.44

AMGN cash-secured put risk and reward

Net Premium / Debit
+$243.50
Max Profit (per contract)
$243.50
Max Loss (per contract)
-$30,755.50
Breakeven(s)
$307.57
Risk / Reward Ratio
0.008

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

AMGN cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on AMGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-100.0%-$30,755.50
$72.35-77.9%-$23,521.26
$144.69-55.8%-$16,287.02
$217.04-33.7%-$9,052.78
$289.38-11.6%-$1,818.54
$361.72+10.6%+$243.50
$434.06+32.7%+$243.50
$506.41+54.8%+$243.50
$578.75+76.9%+$243.50
$651.09+99.0%+$243.50

When traders use cash-secured put on AMGN

Cash-secured puts on AMGN earn premium while a trader waits to acquire AMGN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning AMGN.

AMGN thesis for this cash-secured put

The market-implied 1-standard-deviation range for AMGN extends from approximately $304.82 on the downside to $349.56 on the upside. A AMGN cash-secured put lets a trader earn premium while waiting to acquire AMGN at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current AMGN IV rank near 22.47% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AMGN at 23.85%. As a Healthcare name, AMGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMGN-specific events.

AMGN cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMGN alongside the broader basket even when AMGN-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on AMGN carry tail risk when realized volatility exceeds the implied move; review historical AMGN earnings reactions and macro stress periods before sizing. Always rebuild the position from current AMGN chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on AMGN?
A cash-secured put on AMGN is the cash-secured put strategy applied to AMGN (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With AMGN stock trading near $327.19, the strikes shown on this page are snapped to the nearest listed AMGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AMGN cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the AMGN cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 23.85%), the computed maximum profit is $243.50 per contract and the computed maximum loss is -$30,755.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AMGN cash-secured put?
The breakeven for the AMGN cash-secured put priced on this page is roughly $307.57 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMGN market-implied 1-standard-deviation expected move is approximately 6.84%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on AMGN?
Cash-secured puts on AMGN earn premium while a trader waits to acquire AMGN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning AMGN.
How does current AMGN implied volatility affect this cash-secured put?
AMGN ATM IV is at 23.85% with IV rank near 22.47%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related AMGN analysis